{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T20:07:32Z","timestamp":1766088452564,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ajoc.2025.102345","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T18:54:34Z","timestamp":1746298474000},"page":"102345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Uveal melanoma following Bruton's tyrosine inhibitor use for the treatment of hematologic malignancies"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4712-0953","authenticated-orcid":false,"given":"Tara","family":"Murty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan H.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1087-9736","authenticated-orcid":false,"given":"Prithvi","family":"Mruthyunjaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajoc.2025.102345_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/eye.2016.275","article-title":"Uveal melanoma: relatively rare but deadly cancer","volume":"31","author":"Kaliki","year":"2017","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102345_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jha2.366","article-title":"Second primary malignancies in chronic lymphocytic leukaemia: skin, solid organ, haematological and Richter's syndrome","volume":"3","author":"Shen","year":"2022","journal-title":"eJHaem"},{"issue":"September 2020","key":"10.1016\/j.ajoc.2025.102345_bib5","article-title":"Second primary malignancies in multiple myeloma: a review","volume":"46","author":"Poh","year":"2021","journal-title":"Blood Rev"},{"issue":"20","key":"10.1016\/j.ajoc.2025.102345_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11206139","article-title":"Bruton's tyrosine kinase inhibitors: the next frontier of B-Cell-Targeted therapies for cancer, autoimmune disorders, and multiple sclerosis","volume":"11","author":"Garg","year":"2022","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.ajoc.2025.102345_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15071996","article-title":"Efficacy and safety of Bruton tyrosine kinase inhibitor monotherapy compared with combination therapy for chronic lymphocytic leukemia and small lymphocytic lymphoma: a systematic review and meta-analysis","volume":"15","author":"Nguyen","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ajoc.2025.102345_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28052400","article-title":"Bruton's tyrosine kinase inhibitors (BTKIs): review of preclinical studies and evaluation of clinical trials","volume":"28","author":"Rozkiewicz","year":"2023","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.ajoc.2025.102345_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12061312","article-title":"Underlying ciliary body uveal melanoma in a patient with chronic lymphocytic leukemia presenting for hyphema","volume":"12","author":"P\u0103s\u0103ric\u0103","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.ajoc.2025.102345_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.727531","article-title":"Multifaceted immunomodulatory effects of the BTK inhibitors ibrutinib and acalabrutinib on different immune cell subsets \u2013 beyond B lymphocytes","volume":"9","author":"Zhu","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102345_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-022-01353-w","article-title":"BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies","volume":"15","author":"Alu","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"7642","key":"10.1016\/j.ajoc.2025.102345_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nature21406","article-title":"Phosphatidylinositol 3-kinase \u03b4 blockade increases genomic instability in B cells","volume":"542","author":"Compagno","year":"2017","journal-title":"Naturen"},{"issue":"13","key":"10.1016\/j.ajoc.2025.102345_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133066","article-title":"GNAQ and GNA11 genes: a comprehensive review on oncogenesis, prognosis and therapeutic opportunities in uveal melanoma","volume":"14","author":"Silva-Rodr\u00edguez","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"16","key":"10.1016\/j.ajoc.2025.102345_bib14","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1158\/0008-5472.CAN-14-3229","article-title":"Protein GNAQ induces uveal melanoma and intravasation in mice","volume":"75","author":"Huang","year":"2015","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.ajoc.2025.102345_bib15","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1006\/geno.1995.1267","article-title":"Molecular cloning of human g\u03b1q cDNA and chromosomal localization of the g\u03b1q gene (GNAQ) and a processed pseudogene","volume":"30","author":"Dong","year":"1995","journal-title":"Genomics"},{"issue":"21","key":"10.1016\/j.ajoc.2025.102345_bib16","doi-asserted-by":"crossref","first-page":"12197","DOI":"10.1073\/pnas.95.21.12197","article-title":"Identification of the binding site for Gq\u03b1 on its effector Bruton's tyrosine kinase","volume":"95","author":"Ma","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.ajoc.2025.102345_bib17","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1038\/s41375-020-0987-6","article-title":"Second cancer incidence in CLL patients receiving BTK inhibitors","volume":"34","author":"Bond","year":"2020","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102345_bib18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jha2.146","article-title":"Acalabrutinib-related second primary malignancies and nonmelanoma skin cancers in patients with chronic lymphocytic leukaemia (CLL): a systematic review and meta-analysis of randomised controlled trials (RCTs)","volume":"2","author":"Htut","year":"2021","journal-title":"eJHaem"},{"key":"10.1016\/j.ajoc.2025.102345_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejca.2021.10.034","article-title":"Ibrutinib-related skin cancer: a pharmacovigilance study from the Food and drug administration adverse event reporting system","volume":"160","author":"Sun","year":"2022","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.ajoc.2025.102345_bib20","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.mayocp.2014.08.012","article-title":"Clinical and histologic findings in patients with uveal melanomas after taking tumor necrosis factor-\u03b1 inhibitors","volume":"89","author":"Damento","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.ajoc.2025.102345_bib21","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/bjd.12779","article-title":"Melanoma associated with TNF\u03b1 inhibitors: a research on adverse drug events and reports (RADAR) Project","volume":"170","author":"Nardone","year":"2014","journal-title":"Br J Dermatol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993625000982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993625000982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:29:02Z","timestamp":1760146142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993625000982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":19,"alternative-id":["S2451993625000982"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2025.102345","relation":{},"ISSN":["2451-9936"],"issn-type":[{"type":"print","value":"2451-9936"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uveal melanoma following Bruton's tyrosine inhibitor use for the treatment of hematologic malignancies","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2025.102345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102345"}}